| Spirig HealthCare AG - Co-Amoxicillin Spirig HC 312,5 mg (250/62.5), Pulver zur Herstellung einer Suspension zum Einnehmen |
| 66429 | | 02 | | Co-Amoxicillin Spirig HC 312,5 mg (250/62.5) | | Pulver zur Herstellung einer Suspension zum Einnehmen | | J01CR02 | | Amoxicillin and Beta-Lactamase Inhibitor | | 15.01.2018 | | |
|
| Composition |
| amoxicillinum anhydricum 250 mg ut amoxicillinum trihydricum, acidum clavulanicum 62.5 mg ut kalii clavulanas, arom.: vanillinum et alia, aspartamum, excipiens ad pulverem corresp. suspensio reconstituta 5 ml. |
| Packungsbestandteile |
| Pulver zur Herstellung einer Suspension zum Einnehmen | | | | | | | | Active Agent | Dose |
|---|
| Clavulanic Acid | 62.5 mg | | Amoxicillin Anhydride | 250 mg |
| | BAG: Active Agent | Dose |
|---|
| Clavulanic Acid | 62.5 mg | | Amoxicillin Anhydride | 250 mg |
| | | | Inactive agents | | additional_information |
|---|
| Alia | | | | Aspartame | | | | Vanilline | | arom. |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 002 | 100 ml | 10.33 | 27.70 | A | SL | No |
|
